InspireMD Future Growth
Future criteria checks 2/6
InspireMD is forecast to grow revenue at 51.2% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | 51.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 26 Mar 2024 |
Recent future growth updates
Recent updates
Here's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn Situation
Jan 11We Think InspireMD (NASDAQ:NSPR) Needs To Drive Business Growth Carefully
Jan 27We're Keeping An Eye On InspireMD's (NASDAQ:NSPR) Cash Burn Rate
Oct 05InspireMD: Revolutionizing The Field Of Vascular Stenting
Sep 20Trade Alert: Gary Roubin At InspireMD, Inc. (NYSEMKT:NSPR), Has Just Spent US$150k Buying 52% More Shares
Feb 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 32 | N/A | N/A | N/A | 1 |
12/31/2025 | 15 | N/A | N/A | N/A | 1 |
12/31/2024 | 7 | N/A | N/A | N/A | 1 |
12/31/2023 | 6 | -20 | -17 | -16 | N/A |
9/30/2023 | 5 | -19 | -16 | -15 | N/A |
6/30/2023 | 5 | -19 | -17 | -16 | N/A |
3/31/2023 | 5 | -18 | -17 | -16 | N/A |
12/31/2022 | 5 | -18 | -16 | -16 | N/A |
9/30/2022 | 6 | -18 | -16 | -15 | N/A |
6/30/2022 | 5 | -17 | -15 | -14 | N/A |
3/31/2022 | 5 | -16 | -14 | -14 | N/A |
12/31/2021 | 4 | -15 | -14 | -13 | N/A |
9/30/2021 | 3 | -15 | -13 | -13 | N/A |
6/30/2021 | 3 | -13 | -12 | -11 | N/A |
3/31/2021 | 2 | -12 | -10 | -10 | N/A |
12/31/2020 | 2 | -11 | -9 | -9 | N/A |
9/30/2020 | 3 | -9 | -9 | -8 | N/A |
6/30/2020 | 3 | -9 | -7 | -7 | N/A |
3/31/2020 | 4 | -9 | -9 | -9 | N/A |
12/31/2019 | 4 | -10 | -10 | -10 | N/A |
9/30/2019 | 4 | -10 | -10 | -10 | N/A |
6/30/2019 | 3 | -10 | -10 | -10 | N/A |
3/31/2019 | 3 | -8 | -9 | -9 | N/A |
12/31/2018 | 4 | -8 | -8 | -8 | N/A |
9/30/2018 | 4 | -11 | -8 | -8 | N/A |
6/30/2018 | 4 | -11 | -8 | -8 | N/A |
3/31/2018 | 3 | -12 | -7 | -7 | N/A |
12/31/2017 | 3 | -13 | -8 | -8 | N/A |
9/30/2017 | 2 | -10 | N/A | -8 | N/A |
6/30/2017 | 2 | -10 | N/A | -9 | N/A |
3/31/2017 | 2 | -9 | N/A | -8 | N/A |
12/31/2016 | 2 | -8 | N/A | -7 | N/A |
9/30/2016 | 2 | -9 | N/A | -8 | N/A |
6/30/2016 | 2 | -11 | N/A | -7 | N/A |
3/31/2016 | 2 | -13 | N/A | -9 | N/A |
12/31/2015 | 2 | -16 | N/A | -12 | N/A |
9/30/2015 | 3 | -18 | N/A | -14 | N/A |
6/30/2015 | 2 | -21 | N/A | -18 | N/A |
3/31/2015 | 2 | -24 | N/A | -20 | N/A |
12/31/2014 | 3 | -25 | N/A | -19 | N/A |
9/30/2014 | 4 | -26 | N/A | -18 | N/A |
6/30/2014 | 5 | -23 | N/A | -15 | N/A |
3/31/2014 | 6 | -30 | N/A | -12 | N/A |
12/31/2013 | 6 | -29 | N/A | -11 | N/A |
9/30/2013 | 6 | -26 | N/A | -11 | N/A |
6/30/2013 | 5 | -29 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NSPR's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if NSPR's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NSPR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NSPR's revenue (51.2% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: NSPR's revenue (51.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NSPR's Return on Equity is forecast to be high in 3 years time